Abstract
Drug-device combination products (DDCPs) represent a significant area of development in modern medical treatments, combining pharmaceutical products with medical devices to improve patient outcomes. This article explores recent advances in DDCPs, including new materials, innovations in drug delivery mechanisms, regulatory challenges, and the clinical impact on patients with chronic conditions. The synergy between drug administration and device function can optimize therapeutic efficacy, reducing side effects and improving patient compliance. The article provides an overview of key trends in the field, highlighting both successes and ongoing challenges.
All articles published in the American Journal of Pharmaceutics are open access and licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows users to:
-
Share — copy and redistribute the material in any medium or format
-
Adapt — remix, transform, and build upon the material for any purpose, even commercially
Under the following terms:
-
Attribution — Appropriate credit must be given, a link to the license must be provided, and any changes must be indicated.
-
Authors retain full copyright of their work.
-
The journal does not restrict reuse of content, provided proper citation of the original publication is made.